基于国家儿童肿瘤监测平台的患者主索引构建与应用  

Construction and application of enterprise master patient index based on the national pediatric cancer surveillance platform

作　　者：李哲 徐新[2,4] 李新平 张啸 白国良 王晓瑜 刘莹颖 杨卓煜 卢明 倪鑫 Li Zhe;Xu Xin;Li Xinping;Zhang Xiao;Bai Guoliang;Wang Xiaoyu;Liu Yingying;Yang Zhuoyu;Lu Ming;Ni Xin(National Center for Pediatric Cancer Surveillance,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health,Beijing 100045,China;Information Center,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health,Beijing 100045,China;Hospital Administration Office,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health,Beijing 100045,China;School of Instrumention and Optoelectronic Engineering,Beihang University)

机构地区：[1]国家儿童医学中心、首都医科大学附属北京儿童医院国家儿童肿瘤监测中心,北京100045 [2]国家儿童医学中心、首都医科大学附属北京儿童医院信息中心,北京100045 [3]国家儿童医学中心、首都医科大学附属北京儿童医院办公室,北京100045 [4]北京航空航天大学仪器科学与光电工程学院

出　　处：《中华医院管理杂志》2024年第12期923-927,共5页Chinese Journal of Hospital Administration

基　　金：首都医科大学附属北京儿童医院研究平台专项课题(YPT202001)。

摘　　要：患者主索引是识别多源异构医疗数据中同一患者诊疗记录的重要工具。2021年6—12月,国家儿童肿瘤监测中心基于文献分析和专家咨询法,筛选并确定了患者主索引指标体系及其识别逻辑,并基于国家儿童肿瘤监测平台(以下简称监测平台)开发出相应的智能识别算法系统,经过多轮真实数据的验证与调整,构建出适用于多源异构医疗数据的患者主索引。2022年1月至2024年3月,智能识别算法系统累计完成246万张儿童肿瘤病例报告卡的识别,建立了33万个恶性肿瘤患者主索引及其唯一识别码,提高了监测平台的数据管理和应用效率。基于监测平台的患者主索引在儿童肿瘤病例登记、随访工作及相关医学研究中发挥了重要作用,可为我国其他医疗大数据平台的主索引构建提供借鉴。The enterprise master patient index is an important tool for identifying the diagnosis and treatment records of the same patient in heterogeneous medical data from multiple sources.From June to December 2021,the National Children′s Cancer Monitoring Center screened and determined the enterprise master patient index index system and its recognition logic by literature analysis and expert consultation.Based on the National Children′s Cancer surveillance Platform(hereinafter referred to as the surveillance platform),a corresponding intelligent recognition algorithm system was developed.After multiple rounds of real data verification and adjustment,a enterprise master patient index suitable for multi-source heterogeneous medical data was constructed.From January 2022 to March 2024,the intelligent recognition algorithm system had completed the recognition of 2.46 million pediatric tumor case report cards,established 0.33 million primary indexes and their unique identification codes for malignant tumor patients,and improved the data management and application efficiency of the surveillance platform.The enterprise master patient index based on surveillance platforms had played an important role in the registration and follow-up of pediatric cancer cases and related medical research,which could provide references for the construction of master indexes on other medical big data platforms in China.

关 键 词：儿童肿瘤 患者主索引 唯一识别码 指标体系 识别逻辑 

分 类 号：R73-31[医药卫生—肿瘤]